Immunotherapy of B cell involvement in progression of solid, nonlymphoid tumors
US6224866A · kind A · utility
58Cited by
5References
46Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Oct 4, 1999 |
| Grant date | May 1, 2001 |
| Priority date | — |
| Expiry date | Oct 4, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/505
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for treating a pro-tumor immune response in an individual having, or suspected of having, a pro-tumor immune response, by administering a therapeutically effective amount of an immunotherapeutic composition which binds to a determinant on B cells, resulting in B cell depletion including of B cells that may be involved in promotion of tumor progression. Also provided are immunotherapeutic compositions which can be used for treating a pro-tumor immune response.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.